Facebook
Twitter
LinkedIn
ForwardGME Grand Rounds: Leveraging AI in Oncology
As AI and machine learning revolutionize the field of oncology, it’s essential to harness these groundbreaking technologies with a keen awareness of their limitations. Empowering physicians, patients, and caregivers to effectively utilize data can significantly alleviate financial burdens and enhance patient outcomes.
Join us as to explore how AI and innovation are transforming oncology care and paving the way for better patient experiences.
Target Audience
Residents, fellows, physicians, nurses, allied health professionals, students, pharmacists, pharmacy techs, respiratory therapists, administrators, biostatisticians, and other healthcare professionals interested in participating.
Learning Objectives
- Comprehend the applications of AI in oncology care.
- Analyze the role of machine learning in healthcare.
- Recognize the implications of AI in clinical trials.
2025 Baptist Health Academic Week
Up to 16.75 CMEs/CEs
The 2025 Baptist Health Academic Week brings together healthcare professionals, researchers, and educators to share knowledge, discuss the latest advancements, and collaborate on improving patient care. Join us in this inspiring week as we engage in a variety of educational sessions, workshops and networking events, all aimed at enhancing clinical skills and promoting lifelong learning.
| 5:30 p.m. | Opening Remarks Zuanel Diaz, Ph.D. AVP, Interprofessional Education Baptist Health |
| 5:35 p.m. | Welcome & Introductions Rebecca L. Toonkel, M.D. Senior Associate Dean for Academic Affairs, Associate Professor Florida International University |
| 5:40 p.m. | Leveraging AI in Oncology Soma Sengupta, M.D., Ph.D., MBA, FRCP, FAAN, FANA Division Chief, Neuro-oncology Professor, Neurology University of North Carolina |
| 6:15 p.m. | Q&A |
| 6:30 p.m. | Adjourn |
Moderator
Senior Associate Dean for Academic Affairs; Associate Professor
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
Faculty
Division Chief, Neuro-oncology
Professor, Neurology
University of North Carolina
Chapel Hill, North Carolina
Disclosures and Resolution of Conflicts of Interest
Soma Segunpta, M.D. and Rebecca Toonkel, M.D., faculty of this educational activity, have no relevant financial relationships with ineligible companies* to disclose, and have indicated that the presentations or discussions will not include off-label or unapproved product usage.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.